Filing Details
- Accession Number:
- 0001237899-15-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-18 18:03:39
- Reporting Period:
- 2015-03-16
- Filing Date:
- 2015-03-18
- Accepted Time:
- 2015-03-18 18:03:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1391382 | J Robert Terifay | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Commercial | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-16 | 24,375 | $30.63 | 44,404 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-16 | 1,679 | $444.46 | 42,725 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-03-16 | 11,703 | $444.46 | 31,022 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-03-17 | 2,600 | $448.01 | 28,422 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-17 | 300 | $448.87 | 28,122 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-17 | 2,093 | $450.18 | 26,029 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-17 | 700 | $450.95 | 25,329 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-17 | 3,200 | $452.61 | 22,129 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-17 | 1,700 | $453.28 | 20,429 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-17 | 400 | $454.00 | 20,029 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-03-16 | 24,375 | $0.00 | 24,375 | $30.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
29,236 | 2020-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,651 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 2,600 shares of Company stock on March 17, 2015 at prices ranging from $447.56 to $448.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price.
- Represents volume-weighted average price of sales of 300 shares of Company stock on March 17, 2015 at prices ranging from $448.60 to $449.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price.
- Represents volume-weighted average price of sales of 2,093 shares of Company stock on March 17, 2015 at prices ranging from $449.60 to $450.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price.
- Represents volume-weighted average price of sales of 700 shares of Company stock on March 17, 2015 at prices ranging from $450.75 to $451.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price.
- Represents volume-weighted average price of sales of 3,200 shares of Company stock on March 17, 2015 at prices ranging from $451.99 to $452.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price.
- Represents volume-weighted average price of sales of 1,700 shares of Company stock on March 17, 2015 at prices ranging from $452.99 to $453.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price.
- The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.